Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
Vaccine skeptics have said changes were introduced to "accommodate" the shortcomings of the COVID-19 vaccines.
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...
In fall and winter, COVID-19 transmission usually rises. LA County offers free boosters at county clinics and vaccination ...
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...
Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...
The Semmelweis University Centre for Epidemiology and Disease Surveillance has published the latest data on the spread of ...
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect ...
The CDC is attempting to get the COVID-19 shot into more arms by asking physicians and pharmacists to recommend the updated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback